Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-08
DOI
10.1038/srep19074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer effect of celastrol on human triple negative breast cancer: Possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways
- (2015) Shweta Shrivastava et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway
- (2015) Meilin Shi et al. Molecular Cancer
- The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis
- (2014) Bo Tian et al. BIOMATERIALS
- Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans
- (2014) Archana Kamalakar et al. BONE
- Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells
- (2014) Guo-Sheng Wu et al. Pharmacological Reports
- Effects of Na/K-ATPase and its ligands on bone marrow stromal cell differentiation
- (2014) Moustafa Sayed et al. Stem Cell Research
- Denosumab in breast cancer treatment
- (2013) Jan C. Drooger et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Critical Role of AKT Protein in Myeloma-induced Osteoclast Formation and Osteolysis
- (2013) Huiling Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis
- (2012) LINGYUN ZHANG et al. APMIS
- Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1
- (2012) Qian Ba et al. PLoS One
- Comparative study of dihydroartemisinin and artesunate safety in healthy Thai volunteers
- (2011) S. Kongpatanakul et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Bone metastasis: mechanisms and therapeutic opportunities
- (2011) Larry J. Suva et al. Nature Reviews Endocrinology
- Anti-cancer natural products isolated from chinese medicinal herbs
- (2011) Wen Tan et al. Chinese Medicine
- Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
- (2010) Jin-Jian Lu et al. BIOCHEMICAL PHARMACOLOGY
- Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCα/Raf/MAPKs and NF-κB/AP-1-dependent mechanisms
- (2010) Yong Pil Hwang et al. BIOCHEMICAL PHARMACOLOGY
- Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
- (2010) Jin-Jian Lu et al. CANCER BIOLOGY & THERAPY
- Activating transcription factor 4 regulates osteoclast differentiation in mice
- (2010) Huiling Cao et al. JOURNAL OF CLINICAL INVESTIGATION
- The critical role of the bone microenvironment in cancer metastases
- (2009) Sandra Casimiro et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Effect of bisphosphonates on pain and quality of life in patients with bone metastases
- (2009) Luis Costa et al. Nature clinical practice. Oncology
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
- (2008) J. Hou et al. CLINICAL CANCER RESEARCH
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
- Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways
- (2007) Jin-Ping Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started